SUA <0.36mmol/l Acute Treatment Treat pain and inflammation as soon as possible, continuing until acute flare has settled Full dose NSAID (eg naproxen.

Slides:



Advertisements
Similar presentations
Type 2 diabetes Implementing NICE guidance 2009 NICE clinical guideline 87.
Advertisements

Little Rheumatology gems for GP Trainees HDR 7/12/10 Hayley Faries, ST1 Rheumatology.
Team Meeting Presentations
Management of Stroke and Transient Ischaemic Attack Sam Thomson.
TXF Caveat on urate levels Serum uric acid level may be normal at the time of an acute attack. Normal level does not rule out gout. May be better.
Prepared by : Tamara Odeh Diana Jawhari Supervised by : Dr. Ola Ayesh.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 74 Drug Therapy of Gout.
Arthritis New Zealand Gout Georgina Greville RN Arthritis Educator.
BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:
Gout: Its not all crystal clear Robert L. Wortmann, M.D. Department of Internal Medicine The University of Oklahoma College of Medicine, Tulsa.
1 Uric acid and Gout James Witter MD, PhD Arthritis Advisory Meeting June 2, 2004.
Familial metabolic disease Characterized by : Acute arthritis Uric stones in the kidneys Hyperuricemia.
Pharmacological Treatment of Hypertension Update 2012.
Treatment of Arthritis.  Arthritis is a form of joint disorder that involves inflammation of one or more joints. inflammation  There are over 100 different.
GOUT TREATMENT. Gout prevalence doubled over the last 20 yrs. Factors? - longevity - diuretic use - low dose ASA - obesity - end stage renal disease -
Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.
Clinical cases.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
Treatment of Arthritis Dr. Kaukab Azim. Medicinal Treatment for Arthritis Pain Relief: The most common medication used for acute pain relief are.
Hypertension NICE CG127 August Hypertension is not a disease it is a risk factor for cardiovasuclar disease (CVD)-it is a modifiable risk factor.
Clinical Case #6 By Chen, chun-Yu (Kim) Chen, I -chun (Afra) Chen, I -chun (Afra)
Summary Lecture Gout/Glaucoma Learning Outcomes Predict the activity of a drug based on its structure & physiochemical properties Demonstrate an understanding.
Management. Problems Chronic tophaceous gout in flare Ulcers on sole of left foot Leukocytosis with neutrophilia Anemia and possible GI bleeding Hypertension.
TAP PHARMACEUTICAL PRODUCTS INC. June 2, Arthritis Drugs Advisory Committee TAP Pharmaceutical Products Inc. June 2, 2004.
Primary care team meeting Hypertension Dr Som Desilva.
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
GOUT. Demographics Affects middle-aged to elderly men postmenopausal and elderly women (usually have OA and HPN causing mild renal insufficiency, and.
Agents Used to Treat Hyperuricemia and Gout
GOUT: DIAGNOSIS AND MANAGEMENT. Gout Metabolic disorder due to excessive accumulation of uric acid in tissues leading to acute and chronic arthritis and.
Gout Treatment Megan Chan, PGY-2 UHCMC Gout Acute gouty arthritis = monosodium urate crystals in synovial fluid leukocytes – Serum urate ≥ 6.8 =
Angelo L Gaffo Kenneth G Saag Core Evidence 2009:4 25–36
Manufacturer: AstraZeneca FDA Approval Date: December 22, 2015
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast NSAIDS – Efficacy and Safety Expert speaker.
Colchicine: Colchicine: Effective & specific gout Rx, but less favored than NSAIDs because of slow onset of action & high incidence of side effects. Effective.
Pain Ladder and Opiate Conversion Christopher Haigh Medicines Optimisation Pharmacist Bolton CCG.
NHS Specialist Pharmacy Service NSAIDS – efficacy and safety Expert speaker Slide set Key content from the NPC NSAIDS QIPP slides is gratefully acknowledged.
Be Aware Of Various Gout Treatments. Gout is a painful condition caused by a rise in the uric acid level in the blood. The uric acid that accumulates.
ANTICOAGULATION The objectives of this section are: To be able to write prescriptions according to local anticoagulation guidelines To know how to prescribe.
Gout Ashley Guzman Primary Care I: Acute and Chronic Health Problems
Diabetes Learning Event 7th October 2016
Crystalopathies Joanna Zalewska.
Gout Asad Khan Consultant Rheumatologist
Gout.
Drug Therapy of Gout 1.
GOUT.
Gout and Hyperuricaemia
Mr. Smith, 51, came to the family doctor because of severe pain in his left knee. The patient gave the pain began suddenly at 2 am, woke him from his.
Gout Management.
Patients aged 85yrs and over
CHAPTER 14: MUSCULOSKELETAL CONDITIONS
Treat to Target in Gout.
Time to Take Gout Seriously
Gout Scott Smith PGY-1 1/11/2018.
TREATMENT OF THE ACUTE GOUT ATTACK:
Pharmacological Treatment of Hypertension Update 2012
Polymyalgia and Giant Cell Arteritis
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

sUA <0.36mmol/l Acute Treatment Treat pain and inflammation as soon as possible, continuing until acute flare has settled Full dose NSAID (eg naproxen 500mg bd or diclofenac 50mg tid +/- PPI) or Full dose oral Colchicine (500mcg 2-4 times daily) or Cortico-steroid (oral prednisolone 30mg od for 5 days or IM methyl prednisolone mg. Where expertise is available consider IA methylprednisolone 40-80mg or triamcinolone 20-40mg) Advise patient to apply an ice pack periodically to affected joint (wrap in a towel to avoid ice burn) Review appointment (4-6 weeks) Assess lifestyle factors, blood pressure, lipid profile and perform serum urate, kidney and liver function & glucose Optimise weight, increase exercise, modify diet, reduce alcohol, treat underlying cardiovascular risk factors Long term treatment Initiate urate lowering therapy if patient has had ≥2 flares per year based on patient preference and clinical judgement First line treatment Allopurinol, Second line Febuxostat, Third line Sulphinpyrazone Co-prescribe low dose NSAID(eg naproxen 250mg bd or diclofenac 25mg TID) +/- PPI or low dose colchicine (500mcg 2 times daily) for at least 6 weeks Reconsider diagnosis Persistent symptoms without diagnosis should be referred to secondary care. Note that serum urate frequently falls during gout attacks, so it is important that serum urate is measured after resolution of the flare. sUA ≥ 0.36mmol/l Repeat sUA (2-4 weeks) sUA ≥ 0.36mmol/lsUA <0.36mmol/l Titrate up urate lowering therapy (please see separate flow chart for prescribing in renal impairment and details of drug dosage) Maintain prophylactic colchicine for up to 6 months during dose titration  Continue urate lowering therapy unless causing side effects  Repeat convalescent serum urate in patients suffering recurrent attacks Likely diagnosis of gout (exclude septic arthritis)

Start 100mg allopurinol od Maximum 900mg od eGFR <10 Commence 80mg febuxostat od with 6 months colchicine 500mcg 1-2 tab daily if tolerated Escalate to 120mg febuxostat od after 2-4 weeks if target urate not achieved Start sulfinpyrazone 200mg od and titrate to maximum 800mg od Consider adding allopurinol if no contra-indication Refer to secondary care for consideration of benzbromarone +/- further allopurinol titration Intolerance or inefficacy of febuxostat Continue urate lowering therapy through any subsequent attacks Check convalescent serum urate in patients suffering recurrent attacks and escalate treatment if no longer at target Sulfinpyrazone dose may be reduced for maintenance Intolerance/inefficacy of sulfinpyrazone +/- allopurinol Intolerance or inefficacy of allopurinol Urate Lowering Therapy prescribing based on renal function Offer flare prophylaxis for at least 6 weeks with 500mcg colchicine od or bd if tolerated. Measure serum urate every 2-4 weeks and titrate therapy until target of serum urate <0.36mmol/l. Check compliance before assuming inefficacy. Target urate achieved Start 50mg allopurinol od Maximum 100mg od eGFR 20-50eGFR 10-20eGFR >50 Start 100mg allopurinol od Maximum 200mg od Start 100mg allopurinol od Maximum 300mg od eGFR >= 30 eGFR >=90 eGFR <30 eGFR <90 or Target urate achieved